Persona Biomed, Inc.

$1,000,000 to commericalize our 26 diagnostic tests, including a Long Covid complementary test to COVID 19 test.

Facebook Twitter LinkedIn

We are global clinical stage molecular diagnostic test company possessing 26 cancer and high market demand non-cancer issues. Have a very much in demand LONG COVID complimentary test to COVID-19 Virus test that is market ready for global commercialization. Europe is currently using our Breast Cancer, LONG COVID and Obesity test.

Ready to Ask For Funding for your company?

Post a Funding Request

Persona Biomed, Inc. is no longer seeking funding.

Key Facts

Industry
{{model.industry | ffIndustry}}
Location
{{model.city_state}}
Year Founded
{{model.year_founded}}
Monthly Income
{{model.monthly_income | ffIncome}}
Website
{{model.homepage_url}}